Literature DB >> 20306283

Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease.

Vladimir Frecer1, Stanislav Miertus.   

Abstract

Serine protease activity of the NS3 protein of Dengue virus is an important target of antiviral agents that interfere with the viral polyprotein precursor processing catalyzed by the NS3 protease (NS3pro), which is important for the viral replication and maturation. Recent studies showed that substrate-based peptidomimetics carrying an electrophilic warhead inhibit the NS2B-NS3pro cofactor-protease complex with inhibition constants in the low micromolar concentration range when basic amino acid residues occupy P(1) and P(2) positions of the inhibitor, and an aldehyde warhead is attached to the P(1). We have used computer-assisted combinatorial techniques to design, focus using the NS2B-NS3pro receptor 3D structure, and in silico screen a virtual library of more than 9,200 peptidomimetic analogs targeted around the template inhibitor Bz-Nle-Lys-Arg-Arg-H (Bz-benzoyl) that are composed mainly of unusual amino acid residues in all positions P(1)-P(4). The most promising virtual hits were analyzed in terms of computed enzyme-inhibitor interactions and Adsorption, Distribution, Metabolism and Excretion (ADME) related physico-chemical properties. Our study can direct the interest of medicinal chemists working on a next generation of antiviral chemotherapeutics against the Dengue Fever towards the explored subset of the chemical space that is predicted to contain peptide aldehydes with NS3pro inhibition potencies in nanomolar range which display ADME-related properties comparable to the training set inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306283     DOI: 10.1007/s10822-010-9326-8

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  45 in total

1.  Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.

Authors:  I Muegge; Y C Martin; P J Hajduk; S W Fesik
Journal:  J Med Chem       Date:  1999-07-15       Impact factor: 7.446

2.  Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.

Authors:  Santad Chanprapaph; Patchreenart Saparpakorn; Chak Sangma; Pornwaratt Niyomrattanakit; Supa Hannongbua; Chanan Angsuthanasombat; Gerd Katzenmeier
Journal:  Biochem Biophys Res Commun       Date:  2005-05-20       Impact factor: 3.575

3.  Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries.

Authors:  Jun Li; Siew Pheng Lim; David Beer; Viral Patel; Daying Wen; Christine Tumanut; David C Tully; Jennifer A Williams; Jan Jiricek; John P Priestle; Jennifer L Harris; Subhash G Vasudevan
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

4.  Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease.

Authors:  Nigel J Liverton; M Katharine Holloway; John A McCauley; Michael T Rudd; John W Butcher; Steven S Carroll; Jillian DiMuzio; Christine Fandozzi; Kevin F Gilbert; Shi-Shan Mao; Charles J McIntyre; Kevin T Nguyen; Joseph J Romano; Mark Stahlhut; Bang-Lin Wan; David B Olsen; Joseph P Vacca
Journal:  J Am Chem Soc       Date:  2008-03-14       Impact factor: 15.419

Review 5.  Present perspectives on flaviviral chemotherapy.

Authors:  Debapriya Ghosh; Anirban Basu
Journal:  Drug Discov Today       Date:  2008-06-07       Impact factor: 7.851

6.  The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria.

Authors:  K P Peters; J Fauck; C Frömmel
Journal:  J Mol Biol       Date:  1996-02-16       Impact factor: 5.469

7.  The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids.

Authors:  H Li; S Clum; S You; K E Ebner; R Padmanabhan
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.

Authors:  H M Murthy; K Judge; L DeLucas; R Padmanabhan
Journal:  J Mol Biol       Date:  2000-08-25       Impact factor: 5.469

9.  Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization.

Authors:  Robert B Perni; Janos Pitlik; Shawn D Britt; John J Court; Lawrence F Courtney; David D Deininger; Luc J Farmer; Cynthia A Gates; Scott L Harbeson; Rhonda B Levin; Chao Lin; Kai Lin; Young-Choon Moon; Yu-Ping Luong; Ethan T O'Malley; B Govinda Rao; John A Thomson; Roger D Tung; John H Van Drie; Yunyi Wei
Journal:  Bioorg Med Chem Lett       Date:  2004-03-22       Impact factor: 2.823

10.  MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.

Authors:  Nigel J Liverton; Steven S Carroll; Jillian Dimuzio; Christine Fandozzi; Donald J Graham; Daria Hazuda; M Katherine Holloway; Steven W Ludmerer; John A McCauley; Charles J McIntyre; David B Olsen; Michael T Rudd; Mark Stahlhut; Joseph P Vacca
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

View more
  6 in total

1.  How accurate is the description of ligand-protein interactions by a hybrid QM/MM approach?

Authors:  Jakub Kollar; Vladimir Frecer
Journal:  J Mol Model       Date:  2017-12-12       Impact factor: 1.810

2.  Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.

Authors:  Vladimir Frecer; Pierfausto Seneci; Stanislav Miertus
Journal:  J Comput Aided Mol Des       Date:  2010-11-17       Impact factor: 3.686

3.  High content screening of a kinase-focused library reveals compounds broadly-active against dengue viruses.

Authors:  Deu John M Cruz; Andrea Cristine Koishi; Juliana Bosso Taniguchi; Xiaolan Li; Rafaela Milan Bonotto; Joo Hwan No; Keum Hyun Kim; Sungmin Baek; Hee Young Kim; Marc Peter Windisch; Ana Luiza Pamplona Mosimann; Luana de Borba; Michel Liuzzi; Michael Adsetts Edberg Hansen; Claudia Nunes Duarte dos Santos; Lucio Holanda Freitas-Junior
Journal:  PLoS Negl Trop Dis       Date:  2013-02-21

4.  New binding site conformations of the dengue virus NS3 protease accessed by molecular dynamics simulation.

Authors:  Hugo de Almeida; Izabela M D Bastos; Bergmann M Ribeiro; Bernard Maigret; Jaime M Santana
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

5.  Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.

Authors:  Maywan Hariono; Sy Bing Choi; Ros Fatihah Roslim; Mohamed Sufian Nawi; Mei Lan Tan; Ezatul Ezleen Kamarulzaman; Nornisah Mohamed; Rohana Yusof; Shatrah Othman; Noorsaadah Abd Rahman; Rozana Othman; Habibah A Wahab
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

6.  Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease.

Authors:  Vladimir Frecer; Stanislav Miertus
Journal:  RSC Adv       Date:  2020-11-04       Impact factor: 4.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.